Opinion
12hon MSNOpinion
Trump’s stated reasons for taking Greenland are wrong – but the tactics fit with the plan to limit China’s economic interests
Trump said on his social media platform Truth Social in late December 2024 that, for purposes of national security, U.S. control over Greenland was a necessity. The president has continued to insist ...
The Wall Street Journal opinion in the Reformer on Friday, Jan. 16 ("About that 'disappearing' middle class"), presents dollar amounts for various economic classes to try to make the point ...
Donald Trump said he would not attend an emergency meeting of the G7 in Paris with Emmanuel Macron. The French president had ...
Stay informed with the latest breaking news from Afghanistan. Politics, business, sports, and culture updates in English – ...
President Donald Trump's push to control Greenland has sparked major tensions with Europe. European leaders warn Trump's ...
Travelbinger on MSN
The 5 countries where tourism has become a social flashpoint
Picture this: you’re strolling through a historic neighborhood, soaking in centuries-old architecture, when suddenly you ...
Slingshot News on MSN
'Without tariffs, they wouldn't even be talking to us about it': Trump wrestles with cognitive decline, confuses Iceland and Greenland during briefing
During his remarks in a press briefing today, President Trump mixed up Iceland and Greenland. Trump stated, "Without tariffs, they wouldn't even be talking to us about it." ...
A portrait of Kathleen Chalfant, wearing black and sitting on a tan couch.
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.
Bullish on growth prospects of his group's financial services businesses, industrialist Anil Ambani on Wednesday (30 ...
NIB has provided a €50 million, seven-year loan to TDC NET A/S to finance fibre broadband network rollout investments in Denmark during 2025–2027, with a focus on the Greater Copenhagen area. The ...
EQT Life Sciences Backs Exciva with €51 Million Financing to Address Unmet Needs in Alzheimer’s Care
EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results